News

Decrypt1h
GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee
Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...
Medical Marketing & Media3h
Rx Rundown: Sarep­ta Ther­a­peu­tics, Juul, Pfizer and more
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.